Invention Grant
- Patent Title: Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides for therapeutic use
-
Application No.: US16308796Application Date: 2017-07-31
-
Publication No.: US10730905B2Publication Date: 2020-08-04
- Inventor: Michal Hocek , Anna Tokarenko , Sabina Smolen , Marian Hajduch , Petr Dzubak
- Applicant: USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. , UNIVERZITA PALACKEHO V OLOMOUCI
- Applicant Address: CZ Prague CZ Olomouc
- Assignee: USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I.,UNIVERZITA PALACKEHO V OLOMOUCI
- Current Assignee: USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I.,UNIVERZITA PALACKEHO V OLOMOUCI
- Current Assignee Address: CZ Prague CZ Olomouc
- Agency: Notaro, Michalos & Zaccaria P.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2aaa0c6f
- International Application: PCT/CZ2017/050031 WO 20170731
- International Announcement: WO2018/024265 WO 20180208
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K31/4985 ; A61K31/407 ; A61K31/341 ; C07D487/16 ; C07D487/14 ; C07D491/14 ; C07D491/16 ; C07H19/23 ; A61P35/02 ; C07H19/24
Abstract:
Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides of general formula I, where R is selected from the group comprising furan-2-yl, furan-3-yl, benzofuran-2-yl, methylsulfanyl, methoxy, amino, dimethylamino, methyl or chloro, and pharmaceutically acceptable salt thereof, their optical isomers and mixtures of such optical isomers.
Public/Granted literature
- US20190144486A1 SUBSTITUTED HETEROPENTADIENO-PYRROLOPYRIMIDINE RIBONUCLEOSIDES FOR THERAPEUTIC USE Public/Granted day:2019-05-16
Information query
IPC分类:
